News
GlobalData on MSN23h
Dosing begins in Tiziana Life Sciences’ trial of foralumab for na-SPMSTiziana Life Sciences has announced the commencement of dosing in the fourth clinical site of the company’s Phase II trial of ...
Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback